Urology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Dalbagni G – In summary, although most studies have shown the superiority of intravesical BCG over MMC, the optimized delivery of MMC, which has been shown to be superior to the standard delivery, has not been adequately evaluated in a head–to–head comparison with BCG. At this time, MMC should be considered a viable option for patients with papillary tumors at low to intermediate risk of progression, particularly because of the lower morbidity associated with MMC.

Related Articles

High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression
BMC Cancer, 11/13/09    Relevance Score: 70%

Evidence-based Principles of Bladder Cancer and Diet
Urology, 10/21/09    Relevance Score: 70%

Incidence analyses of bladder cancer in the Nile delta region of Egypt
Cancer Epidemiology, 10/20/09    Relevance Score: 70%

Biomarkers in bladder cancer
BJU International, 10/01/09    Relevance Score: 70%

Diagnosis and Treatment of Bladder Cancer
American Family Physician, 10/01/09    Relevance Score: 70%

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address